Cannabis, a safe anti-inflammatory that slows brain aging can combat the deadly effects of Alzheimer’s Disease a new study details. But cannabis is also considered a Schedule 1 drug with no medical use. Could this new report help alter our government’s perception of pot?
Originally published in the Journal of Alzheimer’s Disease the report’s findings “strongly suggest that THC could be a potential therapeutic treatment option for Alzheimer’s disease through multiple functions and pathways,” notes the authors.
Alzheimer’s Disease currently affects more than five million people and that number is likely to only increase until an effective cure is discovered. Journalist David Downs notes that one in three seniors will die with Alzheimer’s or another dementia. He also points out that Alzheimer’s is the sixth leading cause of death in the nation, costing America about $203 billion in 2013.
Smoking, vaping, or eating the marijuana molecules THC and CBD directly effects nerve cell function, reducing chronic brain inflammation, oxidative stress, and cellular dysfunction — all the while promoting stability of the human body’s internal environment (homeostasis) and healthy brain cells (neurotrophic support), studies show.
Read why the pharmaseutical AN 627 is not Stuff Stoners Like
Downs also notes that our government has patented marijuana molecule CBD as a neuroprotectant. And this is the same ruling class that maintains that marijuana is a schedule 1 drug with no medical use and high potential for abuse.
What do you think our government is going to do with that patent? Let us know your thoughts in the comments below…
GOLDMINE GUMMIES? Stuff Stoners Like?
Democratic Senators Rally for Weed Legalization
Get Paid to Smoke Weed
SF cancels HUGE 420 Celebration!
The duration differs based on various factors...